Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: The role of heparin sodium salt and the PLGA-based microsphere approach
Source abstract
Abstract
New vessel formation is the result of the complex orchestration of various elements, such as cells, signalling molecules and extracellular matrix (ECM). In order to establish the suitable conditions for an effective cell response, the influence of vascular endothelial growth factor (VEGF) complexation with heparin sodium salt (Hp) on its pro-angiogenic activity has been evaluated by an in vitro capillary-like tube formation assay. VEGF with or without Hp was embedded into collagen gels, and the activated matrices were characterized in terms of VEGF activity and release kinetics. Taking into account the crucial role of Hp in VEGF stability and activity, VEGF/Hp complex was then encapsulated into microspheres based on poly(lactide-co-glycolide) (PLGA), and microsphere properties, VEGF/Hp release kinetics and VEGF in vitro activity over time were evaluated. Integrated microsphere/collagen matrices were developed in order to provide a continuous release of active VEGF/Hp inside the matrix but also a VEGF gradient at the boundary, which is an essential condition for endothelial cell attraction and scaffold invasion. The results confirmed a strong influence of Hp on VEGF configuration and, consequently, on its activity, while the encapsulation of VEGF/Hp complex in PLGA-microspheres guaranteed a sustained release of active VEGF for more than 30days. This paper confirms the importance of VEGF stability and signal presentation to cells for an effective proangiogenic activity and highlights how the combination of two stabilizing approaches, namely VEGF/Hp complexation and entrapment within PLGA-based microspheres, may be a very effective strategy to achieve this goal.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Angiogenesis and VEGF in Cancer · Electrospun Nanofibers in Biomedical Applications · Proteoglycans and glycosaminoglycans research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Engineering vascularised tissues in vitro10.22203/eCM.v015a03 ↗
2. Extracellular matrix in angiogenesis: dynamic structures with translational potential10.1111/j.1600-0625.2011.01309.x ↗
3. Synthetic extracellular matrices for tissue engineering10.1007/s11095-008-9541-3 ↗
4. Controlled drug delivery in tissue engineering10.1016/j.addr.2007.08.038 ↗
5. A multi-functional scaffold for tissue regeneration: the need to engineer a tissue analog10.1016/j.biomaterials.2007.07.030 ↗
6. The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF10.1016/j.biomaterials.2009.05.030 ↗
7. Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells10.1083/jcb.200906044 ↗
8. Determinants of cell–material crosstalk at the interface: towards engineering of cell instructive materials10.1098/rsif.2012.0308 ↗
9. Collagen gel systems for sustained delivery and tissue engineering10.1016/j.addr.2003.08.004 ↗
10. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres10.1002/jbm.a.32332 ↗
11. Spatially guided angiogenesis by three-dimensional collagen scaffolds micropatterned with vascular endothelial growth factor
12. Biomedical applications of collagen10.1016/S0378-5173(01)00691-3 ↗
13. Induction of directional sprouting angiogenesis by matrix gradients10.1002/jbm.a.30896 ↗
14. Tissue regeneration based on growth factor release10.1089/10763270360696941 ↗
15. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications10.1016/j.addr.2007.03.012 ↗
16. The biology of VEGF and its receptors10.1038/nm0603-669 ↗
17. PCL microspheres based functional scaffolds by bottom-up approach with predefined microstructural properties and release profiles10.1016/j.biomaterials.2008.09.007 ↗
18. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D ↗
19. Development of poly-(d,l-lactide–coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis10.1016/S0168-3659(01)00258-9 ↗
20. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model10.1211/002235702760089009 ↗
21. In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres10.1002/mrm.20092 ↗
22. Temporally regulated delivery of VEGF in vitro and in vivo10.1002/jbm.a.30771 ↗
23. Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-coglycolide): protein stability and the effects of stabilizing excipients10.1016/S0939-6411(96)00017-3 ↗
24. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate10.1038/337471a0 ↗
25. Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics10.1016/j.jconrel.2006.04.011 ↗
26. Maintenance of vascular endothelial growth factor and potentially other therapeutic proteins bioactivity during a photo-initiated free radical crosslinking reaction forming biodegradable elastomers10.1016/j.ejpb.2006.08.006 ↗
27. Angiogenesis assays: a critical overview10.1373/49.1.32 ↗
28. In vitro models of angiogenesis10.1007/s00268-006-0763-4 ↗
29. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells10.1016/0006-291X(89)92678-8 ↗
30. Regulation of microvascular permeability by vascular endothelial growth factors10.1046/j.1469-7580.2002.00066.x ↗
31. The splice variants of vascular endothelial growth factor (VEGF) and their receptors10.1242/jcs.114.5.853 ↗
32. Repair of large full-thickness articular cartilage defects with allograft articular chondrocytes embedded in a collagen gel10.1089/ten.1998.4.429 ↗
33. In vitro culture characteristics of corneal epithelial, endothelial, and keratocyte cells in a native collagen matrix10.1089/107632700418038 ↗
34. Controlled release of vascular endothelial growth factor by use of collagen hydrogels10.1163/156856200744101 ↗
35. Effects of VEGF temporal and spatial presentation on angiogenesis10.1016/j.biomaterials.2009.10.052 ↗
36. Protein instability in poly(lactic-co-glycolic acid) microparticles10.1023/A:1026498209874 ↗
37. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide)10.1038/71916 ↗
38. Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons10.1016/S0142-9612(00)00141-1 ↗
39. Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres10.1016/S0168-3659(00)00352-7 ↗
40. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres10.1002/jbm.a.10542 ↗
41. Nanoparticles based on PLGA:poloxamer blends for the delivery of proangiogenic growth factors10.1021/mp1001262 ↗
42. New challenge in biomaterials10.1126/science.8134835 ↗
43. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices10.1097/00007890-200205270-00011 ↗